Novavax, Inc. (NVAX) revenue

Revenue · fiscal 2025
$1.12B

Novavax, Inc. (NVAX) reported revenue of $1.12B in fiscal 2025 (the year ended December 31, 2025). That is 64.7% higher than the $682.16M of fiscal 2024. Figures as of 18 Nov 2026, 12:10 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$1.12B
Change on fiscal 2024
+64.7%
Growth, 5 years
+18.8% a year
Growth, 10 years
+41.0% a year
Highest on record
$1.60Bfiscal 2022
Lowest on record
$343.00Kfiscal 2010
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Novavax, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 18.8% a year; over ten years the rate was 41.0% a year. Across the 16 fiscal years on record (2010–2025), the highest was $1.60B in fiscal 2022 and the lowest $343.00K in fiscal 2010.

History · 16 fiscal years

Revenue by fiscal year

Novavax, Inc. revenue, year by year

Novavax, Inc. (NVAX) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$1.12B 64.7% up
2024$682.16M 22.6% up
2023$556.38M 65.2% down
2022$1.60B 39.5% up
2021$1.15B 141.0% up
2020$475.60M 2,448.5% up
2019$18.66M 45.6% down
2018$34.29M 10.0% up
2017$31.18M 103.1% up
2016$15.35M 57.6% down
2015$36.25M 18.2% up
2014$30.66M 46.6% up
2013$20.92M 5.3% down
2012$22.08M 50.3% up
2011$14.69M 4,182.2% up
2010$343.00K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on NVAX

Novavax, Inc., figure by figure

Novavax, Inc. (NVAX) overview: price, valuation and scorecard

Novavax, Inc. revenue: questions and answers

What is Novavax, Inc.'s revenue?

Novavax, Inc. (NVAX) reported revenue of $1.12B in fiscal 2025 (the year ended December 31, 2025). That is 64.7% higher than the $682.16M of fiscal 2024.

What is the growth rate of Novavax, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 18.8% a year; over ten years the rate was 41.0% a year.

What are the highest and lowest revenue figures on record for Novavax, Inc.?

Across the 16 fiscal years on record (2010–2025), the highest was $1.60B in fiscal 2022 and the lowest $343.00K in fiscal 2010.

How is Novavax, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Novavax, Inc. it is on record here for 16 fiscal years, 2010 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Novavax, Inc. (NVAX) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/NVAX/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.